Literature DB >> 3042568

Blood binding and tissue uptake of drugs. Recent advances and perspectives.

J P Tillement1, S Urien, P Chaumet-Riffaud, P Riant, F Bree, D Morin, E Albengres, J Barre.   

Abstract

The free drug hypothesis, which states that only the unbound moiety of drug in blood is available for tissue diffusion, is discussed according to recent investigations. In some experimental conditions, it must be assumed that part of the protein-bound drug in plasma is extracted during a single passage through the organ studied. The mechanisms underlying these observations are not unequivocal and remain hypothetical. In the liver, high-affinity binding sites for serum albumin have been demonstrated, and they would explain the high extraction by liver of endogenous and exogenous compounds. However, these experiments measure the unidirectional transfer of a drug from the vascular to the extravascular space in non-steady-state conditions. Hence, in steady-state conditions, the free drug hypothesis cannot be ruled out because it is supported by numerous pharmacokinetic studies.

Mesh:

Substances:

Year:  1988        PMID: 3042568     DOI: 10.1111/j.1472-8206.1988.tb00634.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  5 in total

1.  A model of cefoperazone tissue penetration: diffusion coefficient and protein binding.

Authors:  A Meulemans
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

Review 2.  Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding.

Authors:  F Hervé; S Urien; E Albengres; J C Duché; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

3.  Blood-to-brain transfer of various oxicams: effects of plasma binding on their brain delivery.

Authors:  P Jolliet; N Simon; F Brée; S Urien; A Pagliara; P A Carrupt; B Testa; J P Tillement
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

4.  Chronopharmacokinetics of Cyclosporine A in the Wistar rat following oral administration.

Authors:  M F Malmary; K Kabbaj; C Labat; A Batalla; I Houti; S Moussamih; J Oustrin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Apr-Jun       Impact factor: 2.441

5.  Peripheral Administration of a Long-Acting Peptide Oxytocin Receptor Agonist Inhibits Fear-Induced Freezing.

Authors:  Meera E Modi; Mark J Majchrzak; Kari R Fonseca; Angela Doran; Sarah Osgood; Michelle Vanase-Frawley; Eric Feyfant; Heather McInnes; Ramin Darvari; Derek L Buhl; Natasha M Kablaoui
Journal:  J Pharmacol Exp Ther       Date:  2016-05-23       Impact factor: 4.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.